2-(5-Bromo-1H-indol-3-yl)-2-oxoacetic acid, 95%, 100mg

2-Chloro-4-vinylpyrimidine, 97%, 500mg

3-Bromostyrene (stabilized with TBC), 95.0%, 1g

Methyl 6-chloro-7-fluoro-1H-indole-2-carboxylate, 1g

4-nitrobenzoic acid, min. 99.5%, 500 g, plastic packaging.

4-Methyl-3-oxo-3,4-dihydro-quinoxaline-2-carboxylic acid, 95.0%, 10g

4-Fluoro-3-methylphenylacetonitrile, 97.0%, 25g

((2R,3R,4S,5R)-3-(Benzoyloxy)-5-bromo-4-fluorotetrahydrofuran-2-yl)methyl benzoate, 97%, 25g

1-Phenyl-3-propyl-2-thiourea, 97%, 5g

Diethyl 3-aminopentanedioate hydrochloride, 97%, 100mg

4-[2-({[(9h-fluoren-9-yl)methoxy]carbonyl}amino)ethoxy]benzoic acid, 97%, 100mg

Bis((R)-4-methyl-4,5-dihydrooxazol-2-yl)methane, 97%, 1g

(Toluene-4-sulfonyloxy)-acetic acid ethyl ester, 95.0%, 5g